Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2009 Dec 1.

Published in final edited form as: Alcohol. 2008 Dec;42(8):675–682. doi: 10.1016/j.alcohol.2008.08.006

Table 3. Liver Enzyme Activity of the Standard Therapy and Probiotic Therapy Groups at Baseline (Day 1) and Following Treatment (Day 7) Compared to Healthy Controls, (M ± SEM).

	Control, n=24	Standard Therapy, n=34		Probiotic Therapy, n=32
	Control, n=24	Day 1	Day 7	Day 1	Day 7
ALT, U/L	22.96 ± 2.4	49.74 ± 7.17^a	51.26 ± 5.25^a	49.84 ± 6.94^a	36.69 ± 4.67^a^,^c
AST, U/L	29.15 ± 2.03	106.80 ± 12.78^a	76.43 ± 5.06^a^,^b	101.06 ± 4.33^a	54.67 ± 7.71^a^,^b^,^c
GGT, U/L	51.88 ± 6.24	152.51 ± 20.16^a	146.89 ± 18.6^a	171.48 ± 26.05^a	142.89 ±18.74^a
LDH, U/L	326.31 ± 10.6	588.57 ± 46.22^a	560.5 ± 56.29^a	560.56 ± 56.29^a	474.17 ± 41.55^a
Total Bilirubin, μmol/l	16.78 ± 0.79	24.15 ± 1.98^a	12.48 ± 1.4^a^,^b	20.75 ± 1.06^a	10.51 ± 0.6^a^,^b

^a

p < 0.05 vs. healthy control group

^b

p < 0.05 Day 1 vs. Day 7

^c

p < 0.05 Standard Therapy vs. Probiotic Therapy